🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareWeekly check-in thread — need advice Page 10

Weekly check-in thread — need advice

greg_boulder Fri, Apr 5, 2024 at 2:30 AM 52 replies 2,715 viewsPage 10 of 11
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Sep 24, 2024 at 2:07 AM#46

Adding the clinical framing, because it changes how the question reads. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

24 24TirzTom, TrialTracker_MD, JennaRN and 21 others
Reply Quote Save Share Report
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
Sep 30, 2024 at 9:54 AM#47

Found this through search years later and it is still the best discussion of the question, so adding one thing. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

23 23kevin_tulsa, Dr.PainCLE, mike_mealprep and 20 others
Reply Quote Save Share Report
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Oct 6, 2024 at 5:45 PM#48
MASHdoc_SA said:
It helps to ask what evidence would change your mind before you look at any.

Adding the part of the answer the thread has not reached. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

22 22SleepFixSam, PurityPaulOR, MaxMetOK and 19 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Oct 13, 2024 at 1:40 AM#49

Adding the numbers, since they settle part of this. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Last edited: Oct 13, 2024 at 4:40 AM
21 21emily_PDX, Dr.SleepRoch, laura_annarbor and 18 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Oct 19, 2024 at 9:38 AM#50

Following on from MASHdoc_SA — and this may be the naive question:

Was that from a primary source or from a summary of one?

49 24JessicaM_2024, TomFromTexas, mike.trainer_LA and 46 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register